TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Skip to content

TD Securities
Client Portals

Capabilities
Sectors
Get To Know
Join Our Team

Search

Search query

TD Securities
Client Portals

Search query

Home
Get to Know TD Cowen
Transactions

$50 Million

Threshold Pharmaceuticals, Inc.

At-the-market Offering

Developer of drugs and diagnostic agents targeting tumors designed to offer a broad potential to treat a variety of cancers.

Related Topics

Biotechnology Equity Capital Markets Health Care North America Pharmaceuticals – Specialty Threshold Pharmaceuticals, Inc.

More Like This

Dec 2020

$150 Million

At-the-market Offering

Dec 2020

$150 Million

At-the-market Offering

Nov 2020

$125 Million

At-the-market Offering

Capabilities
Sectors
Get to Know TD Cowen
Join Our Team

Get In Touch

Headquarters – New York

+1-646-562-1010

View All Locations

@TDCowen
@TDCowenResearch

© 2024, Cowen Inc., All Rights Reserved Regulatory Disclosures FINRA Broker Check Terms of Use Notice for Non-U.S. Investors Privacy

In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.